Oxidative stress is exacerbated in diabetic patients during cardiopulmonary bypass;Exacerbation du stress oxydatif chez les patients diabétiques durant une circulation extracorporelle

Annales de Cardiologie et d'Angeiologie

Volumn 57, Issue 3, 2008, Pages 155-160

  Marty, J C ^b   Bendhadra, S ^b   Amoureux, S ^a   Guilland, J C ^a   Vergely, C ^a   Rochette, L ^a   Girard, C ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Cardiopulmonary bypass; Oxidative stress

Indexed keywords

ASCORBIC ACID; INTERLEUKIN 8; OXYGEN RADICAL;

ANTIOXIDANT ACTIVITY; BLOOD SAMPLING; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CIRCULATION; DIABETIC PATIENT; DISEASE EXACERBATION; ELECTRON SPIN RESONANCE; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; MORBIDITY; MORTALITY; NEUROLOGICAL COMPLICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; PLASMA; SHORT SURVEY; STATISTICAL SIGNIFICANCE;

AGED; ASCORBIC ACID; CARDIOPULMONARY BYPASS; DEHYDROASCORBIC ACID; DIABETES MELLITUS, TYPE 2; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INTERLEUKIN-8; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 46449123025     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2008.02.017     Document Type: Short Survey

References (29)

1. Clermont G., Vergely C., Jazayeri S., Lahet J.J., Goudeau J.J., Lecour S., et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 96 (2002) 80-87
2. Clermont G., Vergely C., Girard C., and Rochette L. Cellular injury associated with extracorporeal circulation. Ann Cardiol Angeiol 51 (2002) 38-43
3. Lehot J.J., Piriz H., Villard J., Cohen R., and Guidollet J. Glucose homeostasis. Comparison between hypothermic and normothermic cardiopulmonary bypass. Chest 102 (1992) 106-111
4. Doenst T., Wijeysundera D., Karkouti K., Zechner C., Maganti M., Rao V., et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 130 (2005) 1144
5. Devos P., Chioléro R., Van den Berghe G., and Preiser J.C. Glucose, insulin and myocardial ischaemia. Curr Opin Clin Nutr Metab Care 9 (2006) 131-139
6. Kersten J.R., Toller W.G., Gross E.R., Pagel P.S., and Warltier D.C. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278 (2000) H1218-H1224
7. Schipke J.D., Friebe R., and Gams E. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials. Eur J Cardiothorac Surg 29 (2006) 479-485
8. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
9. Hess M.L., Okabe E., Poland J., Warner M., Stewart J.R., and Greenfield L.J. Glucose, insulin, potassium protection during the course of hypothermic global ischemia and reperfusion: a new proposed mechanism by the scavenging of free radicals. J Cardiovasc Pharmacol 5 (1983) 35-43
10. Vergely C., Walker M.K., Zeller M., Rademakers J.R., Maupoil V., Schiavi P., et al. Antioxidant properties of indapamide, 5-OH indapamide and hydrochlorothiazide evaluated by oxygen-radical absorbing capacity and electron paramagnetic resonance. Mol Cell Biochem 178 (1998) 151-155
11. Perrin C., Vergely C., Zeller M., and Rochette L. In vitro antioxidant properties of calpain inhibitors: leupeptin and calpain inhibitor-1. Cell Mol Biol (2002) 48
12. Vergely C., Perrin-Sarrado C., Clermont G., and Rochette L. Postischemic recovery and oxidative stress are independent of nitric-oxide synthases modulation in isolated rat heart. J Pharmacol Exp Ther 303 (2002) 149-157
13. Cohen Y., Raz I., Merin G., and Mozes B. Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli coronary artery bypass (ISCAB) study consortium. Am J Cardiol 81 (1998) 7-11
14. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
15. Giugliano D., Ceriello A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19 (1996) 257-267
16. Cosentino F., Hishikawa K., Katusic Z.S., and Lüscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96 (1997) 25-28
17. Kawahito K., Kobayashi E., Ohmori M., Harada K., Kitoh Y., Fujimura A., et al. Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity. Artif Organs 24 (2000) 37-42
18. Laffey J.G., Boylan J.F., and Cheng D.C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97 (2002) 215-252
19. Morse D.S., Adams D., and Magnani B. Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass. Ann Thorac Surg 65 (1998) 691-695
20. Matata B.M., and Galinanes M. Cardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: regulatory effects of exogenous nitric oxide. J Thorac Cardiovasc Surg 120 (2000) 1-11
21. Sharma M., Ganguly N.K., Chaturvedi G., Thingnam S.K., Majumdar S., and Suri R.K. Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery. Mol Cell Biochem 247 (2003) 23-30
22. McColl A.J., Keeble T., Hadjinikolaou L., Cohen A., Aitkenhead H., Glenville B., et al. Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem 35 (1998) 616-623
23. Maxwell S.R., Thomason H., Sandler D., Leguen C., Baxter M.A., Thorpe G.H., et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27 (1997) 484-490
24. Maxwell S.R., Thomason H., Sandler H., LeGuen C., Baxter M.A., Thorpe G.H., et al. Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus. Ann Clin Biochem 34 (1997) 638-644
25. Ceriello A., Bortolotti N., Pirisi M., Crescentini A., Tonutti L., Motz E., et al. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care 20 (1997) 1589-1593
26. Tangney C.C., Hankins J.S., Murtaugh M.A., and Piccione Jr. W. Plasma vitamins E and C concentrations of adult patients during cardiopulmonary bypass. J Am Coll Nutr 17 (1998) 162-170
27. Kunt A.S., Selek S., Celik H., Demir D., Erel O., and Andac M.H. Decrease of total antioxidant capacity during coronary artery bypass surgery. Mt Sinai J Med 73 (2006) 777-783
28. Dandona P., Chaudhuri A., Ghanim H., and Mohanty P. Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol 99 (2007) 15B-26B
29. Goudeau J.J., Clermont G., Guillery O., Lemaire-Ewing S., Musat A., Vernet M., et al. In high-risk patients, combination of antiinflammatory procedures during cardiopulmonary bypass can reduce incidences of inflammation and oxidative stress. J Cardiovasc Pharmacol 49 (2007) 39-45